10.25373/ctsnet.5510248.v1 Tal Golesworthy Tal Golesworthy Exstent, Ltd. Ltd. Exstent Personalized External Aortic Root Support Surgery for Asymptomatic Aortic Dilation: 100 Patient Milestone Reached CTSNet 2017 Aorta Aortic Dilation Aortic Root Surgery 2017-10-18 19:33:07 Media https://ctsnet.figshare.com/articles/media/Personalized_External_Aortic_Root_Support_Surgery_for_Asymptomatic_Aortic_Dilation_100_Patient_Milestone_Reached/5510248 Personalized External Aortic Root Support (PEARS) surgery was started in 2004 at the Royal Brompton Hospital, London, and has now been used to treat over 100 patients with asymptomatic aortic dilation related to Marfan Syndrome, Loeys-Dietz Syndrome, Bicuspid Aortic Valve disease, Turner's Syndrome, and various other congenital conditions involving asymptomatic aortic dilation. It retains all of the native structures, but reinforces the aortic root to halt dilation. In this video, PEARS inventor and first patient, Tal Golesworthy, interviews the 100th PEARS patient.<div>Disclosure: Tal Golesworthy is the inventor of PEARS and was the first recipient of a PEARS implant with respect to his own Marfanoid aorta. Mr Golesworthy is a director and shareholder of Exstent, Ltd, which makes the ExoVasc® Personalized External Aortic Root Support.<br></div>